SOURCE: Equity News Circuit

Equity News Circuit

April 26, 2013 08:45 ET

Free Research Reports on AMGN, OPK, SLAB and VOCS Issued by the Bedford Report

Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit

NEW YORK, NY--(Marketwired - Apr 26, 2013) - The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

Amgen, Inc. (NASDAQ: AMGN) shares declined 6.94 percent on volume of nearly 7.5 million shares traded Wednesday to close at $104.93 a share. The biotech company reported revenues of $4.24 billion for the first quarter. According to Bloomberg Industries, analysts had expected revenues of $4.37 billion.

Find out more about Amgen including full access to the free equity report at: www.BedfordReport.com/AMGN

Opko Health Inc. (NYSE: OPK) shares have soared approximately 44.7 percent year-to-date. The company has recently agreed to purchase biopharmaceutical company Prolor Biotech Inc. "With the inclusion of PROLOR's pipeline, OPKO will have four significant products in Phase III clinical development and a robust pipeline of important therapeutic and unique diagnostic products in various stages of development," commented Dr. Phillip Frost, OPKO's Chairman and CEO.

Find out more about Opko Health including full access to the free equity report at: www.BedfordReport.com/OPK

Silicon Laboratories (NASDAQ: SLAB) shares declined 6.02 percent on volume of 1.10 million shares traded Wednesday to close at $39.49. The company reported revenues of $145.4 million for the first quarter, a decrease of 5 percent when compared to the previous quarter.

Find out more about Silicon Laboratories including full access to the free equity report at: www.BedfordReport.com/SLAB

Vocus, Inc. (NASDAQ: VOCS) shares plunged 37.13 percent on volume of over 12.0 million shares traded Wednesday to close at $8.38 a share. For the second quarter of 2013, revenue is expected to be in the range of approximately $45.1 million to $45.5 million. The company reported revenues of $46.3 million for the first quarter.

Find out more about Vocus including full access to the free equity report at: www.BedfordReport.com/VOCS

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information